Skip to main content
. 2015 May 6;15(3):205–211. doi: 10.1007/s40256-015-0120-9
In patients with nonvalvular atrial fibrillation, maintaining stable, therapeutic levels of anticoagulation for stroke prevention is challenging.
Even after 6 months of warfarin therapy, approximately 40 % of international normalized ratio (INR) values were out of the therapeutic range of 2.0–3.0. In addition, patients exposed to INR >4.0 consumed more healthcare resources.
Patient characteristics were not predictive of increased risk of over-anticoagulation, emphasizing the unpredictability of warfarin.